Azitra, Inc. Announces Closing of Initial Public Offering

BRANFORD, Conn., June 21, 2023 /PRNewswire/ — Azitra, Inc. (NYSE American: AZTR) (the “Company”), a biopharmaceutical company focused on developing innovative therapies for precision dermatology using engineered proteins and topical live biotherapeutic products, today announced the closing of its initial public offering of 1,500,000 shares of its common stock at a public offering price of … Read more

European Wellness Signs a Multi-Million MOU for MF3 of Switzerland Supplements & Skincare Exclusivity Distribution for China

BEIJING, June 21, 2023 /PRNewswire/ — A Memorandum of Understanding (MOU) signing ceremony took place in Beijing, China, and signifies an important step for European Wellness Biomedical Group (EW Group) through its Malaysian subsidiary, European Wellness Academy (EWA), to build a digital technology platform in partnership with Shenzhen Dumbo Future Technology Co. (SDFT Co.), the … Read more

Vial Announces Strategic Partnership with Royale International Group

SAN FRANCISCO, June 21, 2023 /PRNewswire/ — Vial, a global tech-driven CRO providing next-generation clinical trial management services, has partnered with the Royale International Group, one of the largest independent logistics providers in the Asia Pacific region. Royale will provide Vial with temperature-controlled logistics solutions for clinical trials. Royale International offers a comprehensive range of services … Read more

As Summer Heats Up, CHOP Researchers Study Caregiver Attitudes Toward Pediatric Vehicular Heatstroke

–While those who were thought to put children at risk were viewed negatively, a large number of caregivers supported education efforts and technology use to reduce heatstroke risk– PHILADELPHIA, June 21, 2023 /PRNewswire/ — Despite prevention efforts, a child dies of heatstroke in a vehicle approximately once every 10 days. According to a new survey … Read more

G FUEL And HoYoverse Introduce New Traveler’s Ale Energy Drink Flavor Inspired by “Genshin Impact”

G FUEL Traveler’s Ale is Available at GFUEL.com While Supplies Last NEW YORK, June 21, 2023 /PRNewswire/ — G FUEL, in partnership with HoYoverse, announced today that its new Traveler’s Ale flavor inspired by the wildly popular open-world adventure RPG Genshin Impact is now available for pre-order in Collector’s Boxes and Tubs at GFUEL.com while supplies … Read more

AccuWeather Creates New Index to Measure and Quantify the Severity of Heat Waves

Heat Waves are the #1 Cause of Weather-Related Deaths in the U.S. AccuWeather Introduces the Only Scale that Tracks the Duration and Severity of Heat Waves, Allowing People to Now Easily Compare the Intensity of Current and Previous Heat Waves STATE COLLEGE, Pa., June 21, 2023 /PRNewswire/ — AccuWeather®, the undisputed leader in Superior Accuracy™ … Read more

Therabody Named to TIME’s List of The TIME100 Most Influential Companies

The Nod Confirms Therabody as Clear Leader in Wellness LOS ANGELES, June 21, 2023 /PRNewswire/ — Therabody, the global pioneer in wellness technology, proudly announces its inclusion in The 2023 TIME100 Most Influential Companies, a list that celebrates companies that are making an extraordinary impact around the world. TIME100 Most Influential Companies 2023 The TIME100 … Read more

VVT Medical receives FDA 510(k) clearance for its ScleroSafe System

FDA Clearance received 60 days from submission and paves way for Commercialization in the United States KFAR SABA, Israel, June 21, 2023 /PRNewswire/ — VVT Medical, a global medical device company, announces today the receipt of a 510(k) clearance for its ScleroSafe™ platform by the U.S. Food and Drug Administration (FDA). ScleroSafe advanced technology by VVT … Read more

Hemophilia Market to Proliferate Immensly, Predicts DelveInsight | Key Companies to Look Out for

The current therapeutic landscape of hemophilia in the United States is driven by several approved therapies. The hemophilia market is estimated to grow for the period 2019-2032. The major reason behind the hemophilia market upsurge is the launch of the most anticipated gene therapies, which are considered as a threat to the current hemophilia market. … Read more